A severe drug shortage has developed, and Hungarian patients may be at the end of the European line.

Hungary faces a severe drug shortage affecting thousands of chronic patients, with no immediate resolution in sight. The shortage began with a key pancreatic enzyme replacement drug, leading to increased reliance on alternatives that are also now scarce. Patients have resorted to panic buying, exacerbating the situation. Despite attempts to import limited supplies from other countries, these measures have proven insufficient. The National Public Health and Medical Officer Service acknowledges the complexity of the issue, citing varying stock levels and market dynamics across countries. The situation raises concerns about Hungary's ability to secure necessary medications amid international supply challenges.